Global Phage Therapy Market 2026 - Players, Regions, Product Types, Application & Forecast Analysis

Chapter 1 Phage Therapy Market Overview

1.1 Phage Therapy Definition

1.2 Global Phage Therapy Market Size Status and Outlook (2019-2032)

1.3 Global Phage Therapy Market Size Comparison by Region (2019-2032)

1.4 Global Phage Therapy Market Size Comparison by Type (2019-2032)

1.5 Global Phage Therapy Market Size Comparison by Application (2019-2032)

1.6 Global Phage Therapy Market Size Comparison by Sales Channel (2019-2032)

1.7 Phage Therapy Market Dynamics

1.7.1 Market Drivers/Opportunities

1.7.2 Market Challenges/Risks

1.7.3 Market News (Products Launch, Mergers, Acquisitions, Expansion, Agreement and Collaborations, Partnerships)

1.7.4 COVID-19 Impacts

1.7.5 Russia-Ukraine War Impacts

1.7.6 US-Israel-Iran War Impacts

Chapter 2 Executive Summary

2.1 Global Phage Therapy Market Snapshot

2.2 Global Phage Therapy Market Volume & Revenue (2019-2025)

2.3 Global Phage Therapy Market Differential Growth Potential Analysis by Type, (2019-2032) (USD Million)

2.4 Global Phage Therapy Market Differential Growth Potential Analysis by Application, (2019-2032) (USD Million)

2.5 Global Phage Therapy Market Differential Growth Potential Analysis by Sales Channels, (2019-2032) (USD Million)

2.6 Global Phage Therapy Market Differential Growth Potential Analysis by Region, (2019-2032) (USD Million)

Chapter 3 Phage Therapy Market Segment Analysis by Player

3.1 Global Phage Therapy Sales and Market Share by Player (2023-2025)

3.2 Global Phage Therapy Revenue and Market Share by Player (2023-2025)

3.3 Global Phage Therapy Average Price by Player (2023-2025)

3.4 Players Competition Situation & Trends (2023-2025)

3.5 Conclusion of Segment by Player

Chapter 4 Phage Therapy Market Segment Analysis by Type

4.1 Global Phage Therapy Market by Type

4.1.1 DsDNA Bacteriophage

4.1.2 SsDNA Bacteriophage

4.1.3 SsRNA Bacteriophage

4.1.4 Others

4.2 Global Phage Therapy Sales and Market Share by Type (2019-2025)

4.3 Global Phage Therapy Revenue and Market Share by Type (2019-2025)

4.4 Global Phage Therapy Average Price by Type (2019-2025)

4.5 Leading Players of Phage Therapy by Type in 2025

4.6 Conclusion of Segment by Type

Chapter 5 Phage Therapy Market Segment Analysis by Application

5.1 Global Phage Therapy Market by Application

5.1.1 Animal Health

5.1.2 Human Health

5.1.3 Agriculture

5.1.4 Food Industry

5.1.5 Others

5.2 Global Phage Therapy Revenue and Market Share by Application (2019-2025)

5.3 Leading Consumers of Phage Therapy by Application in 2025

5.4 Conclusion of Segment by Application

Chapter 6 Phage Therapy Market Segment Analysis by Sales Channel

6.1 Global Phage Therapy Market by Sales Channel

6.1.1 Global Phage Therapy Market, by Direct Channel Market Analysis (2019-2032) (USD Million)

6.1.2 Global Phage Therapy Market, by Distribution Channel Market Analysis (2019-2032) (USD Million)

6.2 Global Phage Therapy Revenue and Market Share by Sales Channel (2019-2025)

6.3 Leading Distributors/Dealers of Phage Therapy by Sales Channel in 2025

6.4 Conclusion of Segment by Sales Channel

Chapter 7 Phage Therapy Market Segment Analysis by Region

7.1 Global Phage Therapy Market Size and CAGR by Region (2019-2032)

7.2 Global Phage Therapy Sales and Market Share by Region (2019-2025)

7.3 Global Phage Therapy Revenue and Market Share by Region (2019-2025)

7.4 North America

7.4.1 North America Market by Country

7.4.2 North America Phage Therapy Market Share by Type

7.4.3 North America Phage Therapy Market Share by Application

7.4.4 United States

7.4.5 Canada

7.4.6 Mexico

7.5 Europe

7.5.1 Europe Market by Country

7.5.2 Europe Phage Therapy Market Share by Type

7.5.3 Europe Phage Therapy Market Share by Application

7.5.4 Germany

7.5.5 United Kingdom

7.5.6 France

7.5.7 Italy

7.5.8 Russia

7.5.9 Spain

7.5.10 Benelux

7.5.11 Poland

7.5.12 Austria

7.5.13 Portugal

7.5.14 Rest of Europe

7.6 Asia-Pacific

7.6.1 Asia-Pacific Market by Country

7.6.2 Asia-Pacific Phage Therapy Market Share by Type

7.6.3 Asia-Pacific Phage Therapy Market Share by Application

7.6.4 China

7.6.5 Japan

7.6.6 Korea

7.6.7 India

7.6.8 Southeast Asia

7.6.9 Australia

7.6.10 Taiwan

7.6.11 Rest of Asia Pacific

7.7 South America

7.7.1 South America Market by Country

7.7.2 South America Phage Therapy Market Share by Type

7.7.3 South America Phage Therapy Market Share by Application

7.7.4 Brazil

7.7.5 Argentina

7.7.6 Colombia

7.7.7 Chile

7.7.8 Peru

7.7.9 Venezuela

7.7.10 Rest of South America

7.8 Middle East & Africa

7.8.1 Middle East & Africa Market by Country

7.8.2 Middle East & Africa Phage Therapy Market Share by Type

7.8.3 Middle East & Africa Phage Therapy Market Share by Application

7.8.4 UAE

7.8.5 Saudi Arabia

7.8.6 South Africa

7.8.7 Egypt

7.8.8 Nigeria

7.9.9 Rest of Middle East & Africa

7.9 Conclusion of Segment by Region

Chapter 8 Profile of Leading Phage Therapy Players

8.1 Phagelux

8.1.1 Company Snapshot

8.1.2 Product/Service Offered

8.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.1.4 Recent Developments

8.2 Intralytix

8.2.1 Company Snapshot

8.2.2 Product/Service Offered

8.2.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.2.4 Recent Developments

8.3 Micreos

8.3.1 Company Snapshot

8.3.2 Product/Service Offered

8.3.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.3.4 Recent Developments

8.4 Eliava BioPreparations

8.4.1 Company Snapshot

8.4.2 Product/Service Offered

8.4.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.4.4 Recent Developments

8.5 Locus Biosciences

8.5.1 Company Snapshot

8.5.2 Product/Service Offered

8.5.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.5.4 Recent Developments

8.6 Pharmex Group

8.6.1 Company Snapshot

8.6.2 Product/Service Offered

8.6.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.6.4 Recent Developments

8.7 Pherecydes Pharma

8.7.1 Company Snapshot

8.7.2 Product/Service Offered

8.7.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.7.4 Recent Developments

8.8 APS Biocontrol

8.8.1 Company Snapshot

8.8.2 Product/Service Offered

8.8.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.8.4 Recent Developments

8.9 Qingdao Phagepharm Bio-tech

8.9.1 Company Snapshot

8.9.2 Product/Service Offered

8.9.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.9.4 Recent Developments

8.10 Zeptometrix

8.10.1 Company Snapshot

8.10.2 Product/Service Offered

8.10.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.10.4 Recent Developments

8.11 Phage International

8.11.1 Company Snapshot

8.11.2 Product/Service Offered

8.11.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.11.4 Recent Developments

8.12 CJ Cheiljedang

8.12.1 Company Snapshot

8.12.2 Product/Service Offered

8.12.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.12.4 Recent Developments

8.13 Aristogene

8.13.1 Company Snapshot

8.13.2 Product/Service Offered

8.13.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.13.4 Recent Developments

8.14 Armata Pharmaceuticals

8.14.1 Company Snapshot

8.14.2 Product/Service Offered

8.14.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.14.4 Recent Developments

8.15 Innophage

8.15.1 Company Snapshot

8.15.2 Product/Service Offered

8.15.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.15.4 Recent Developments

8.16 Adaptive Phage Therapeutics

8.16.1 Company Snapshot

8.16.2 Product/Service Offered

8.16.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.16.4 Recent Developments

8.17 TechnoPhage

8.17.1 Company Snapshot

8.17.2 Product/Service Offered

8.17.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.17.4 Recent Developments

8.18 Cytophage

8.18.1 Company Snapshot

8.18.2 Product/Service Offered

8.18.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.18.4 Recent Developments

8.19 Others

8.19.1 Company Snapshot

8.19.2 Product/Service Offered

8.19.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.19.4 Recent Developments

Chapter 9 Upstream and Downstream Analysis of Phage Therapy

9.1 Industrial Chain of Phage Therapy

9.2 Upstream of Phage Therapy

9.2.1 Raw Materials (If Applicable)

9.2.2 Manufacturing Cost Structure (If Applicable)

9.2.3 Manufacturing Process (If Applicable)

9.3 Downstream of Phage Therapy

9.3.1 Leading Distributors/Dealers of Phage Therapy

9.3.2 Leading Consumers of Phage Therapy

Chapter 10. Global Phage Therapy Market Industry Analysis

10.1. Porter's Five Forces Analysis

10.1.1. Threat of New Entrants

10.1.2. Bargaining Power of Buyers/Consumers

10.1.3. Bargaining Power of Suppliers

10.1.4. Threat of Substitute Types

10.1.5. Intensity of Competitive Rivalry

10.2. Major Growth Avenues within Global Phage Therapy Market

10.2.1. Product Types

10.2.2. Applications

10.2.3. Sales Channels

10.2.4. Country

10.3. Phage Therapy Industry Ecosystem

10.4. Price Trend Analysis (If Applicable)

10.5. Buying Criteria (If Applicable)

10.6. Regulations (If Applicable)

Chapter 11 Development Trend of Phage Therapy (2026-2032)

11.1 Global Phage Therapy Market Size (Sales and Revenue) Forecast (2026-2032)

11.2 Global Phage Therapy Market Size and CAGR Forecast by Region (2026-2032)

11.3 Global Phage Therapy Market Size and CAGR Forecast by Type (2026-2032)

11.4 Global Phage Therapy Market Size and CAGR Forecast by Application (2026-2032)

11.5 Global Phage Therapy Market Size and CAGR Forecast by Sales Channel (2026-2032)

Chapter 12. Import - Export Analysis (If Applicable)

12.1 North America Phage Therapy Import-Export (2019-2025)

12.2 Europe Phage Therapy Import-Export (2019-2025)

12.3 Asia Pacific Phage Therapy Import-Export (2019-2025)

12.4 South America Phage Therapy Import-Export (2019-2025)

12.5 Middle East & Africa Phage Therapy Import-Export (2019-2025)

Chapter 13. Demand-Supply Gap Analysis

13.1 North America Phage Therapy Demand-Supply (2019-2025)

13.2 Europe Phage Therapy Demand-Supply (2019-2025)

13.3 Asia Pacific Phage Therapy Demand-Supply (2019-2025)

13.4 South America Phage Therapy Demand-Supply (2019-2025)

13.5 Middle East & Africa Phage Therapy Demand-Supply (2019-2025)

Chapter 14 Appendix

14.1 Research Methodology

14.2 Data Sources